Argos Therapeutics' immunotherapy technology receives US & EU patents
Argos Therapeutics Inc., a biopharmaceutical company, has recently received patent from the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO).
Original Article: Argos Therapeutics' immunotherapy technology receives US & EU patents
NEXT ARTICLE